Navigation Links
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
Date:11/10/2008

engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic diseases, cancer and autoimmune disorders. In March 2007, the FDA granted marketing approval for the Company's first product, Soliris for all patients with PNH. In June 2007, the European Commission granted marketing approval for Soliris in the European Union for all patients with PNH. The Company is evaluating other potential indications for Soliris, as well as other formulations of eculizumab for additional clinical indications. In addition, Alexion is pursuing development of an anti-CD200 monoclonal antibody as a treatment for patients with cancer, and evaluating development of other antibody product candidates in early stages of development. This press release and further information about Alexion Pharmaceuticals, Inc. can be found at: http://www.alexionpharma.com.

[ALXN:G]


'/>"/>
SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. USC researchers identify key mechanism that regulates the development of stem cells into neurons
2. Cornell researchers study showing evidence of a major environmental trigger for autism
3. Maastricht University researchers produce neural fingerprint of speech recognition
4. Researchers aim to over-stress already taxed mantle cell lymphoma cells
5. Researchers discover new risk factor for cardiovascular disease, and a way to control it
6. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
7. Researchers find predictive tests and early treatment delay progression of blood cell cancer
8. Researchers describe how chronic inflammation can lead to stomach cancer
9. Researchers ID Genetic Markers for Esophageal Cancer
10. Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis
11. Cancer requires support from immune system to develop, UT Southwestern researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 01, 2014 As AndroGel lawsuits and ... Ronald E. Johnson, Jr. has been appointed as co-lead ... other testosterone medications. Since the Fall of 2013, Ron ... worked diligently to investigate and prosecute the claims of ... blood clots as a result of taking testosterone. As ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Growing ... coverage and healthcare reforms are boosting healthcare market ... medicines through discounts and increasing generic consumption is ... approximately 76.7 million in 2013, having grown at ... from 2008. The implementation of the Health Transformation ...
(Date:8/1/2014)... The "Antimicrobial Coatings Market by Type (Silver, Copper, ... and Zinc Omadine), Application (Indoor air/HVAC, Medical, Mold ... and others), & Geography (North America, Europe, Asia-Pacific, ... 2018" analyzes the Antimicrobial Coatings Market with respect ... diverse geographical regions. , Browse 49 market data ...
(Date:8/1/2014)... According to new market research report "Automotive ... Europe, & ROW), by Vehicle Type (Passenger Cars, ... Diesel), by After-Treatment Device (DPF, DOC, SCR, TWC, ... 2019", defines and segments the global automotive exhaust ... in all the regions, and estimates their exhaust ...
(Date:8/1/2014)... August 1, 2014 The Cardiovascular Research ... first report investigations that will be presented at ... symposium. TCT, the world,s premier educational meeting specializing ... 13 17, 2014 at the Walter E. ... research data presented at TCT often direct the ...
Breaking Medicine News(10 mins):Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4
... , , , WASHINGTON, Aug. ... of the health community in mourning the loss of Senator Edward ... causes, particularly the medically underserved. His work in advancing medical innovation ... America,s ability to invest in cures for illnesses that affect patients ...
... , WEDNESDAY, Aug. 26 (HealthDay News) -- Two new European ... use for diagnosing possible heart attacks in emergency room patients, ... 27 issue of the New England Journal of Medicine ... damaged heart cells. Standard practice in most hospitals now calls ...
... the growth of human colon cancer cells, preventing the disease ... The research, published today in EMBO Molecular Medicine , ... growth of tumours, metastatic lesions and cancer stem cells, the ... Colon cancer often begins in a treatable form when ...
... , , NASHVILLE, Tenn., Aug. ... for the Community" campaign as Nashville Mayor Karl Dean, HCA CEO ... attended the 2009 kickoff event for the corporate office,s employee giving ... (Logo: http://www.ne w s com.com/cgi-bin/prnh/20050825/CLTH069LOGO ...
... , , , ... Health Record Association (EHR Association) responded with enthusiasm to the ... nearly $1.2 billion to help hospitals and health care providers ... of the continued implementation of the healthcare IT provisions of ...
... ... Generation and Gender Impact Physician Engagement", , ... Charlotte, NC (Vocus) August 26, 2009 -- Morehead , the human capital ... Engagement." The free hour-long webinar will be broadcast on Wednesday, September 16, 2009 at ...
Cached Medicine News:Health News:Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy 2Health News:Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy 3Health News:Newer, Better Tests for Heart Attacks 2Health News:Newer, Better Tests for Heart Attacks 3Health News:'Hedgehog' pathway may hold key to anti-cancer therapy 2Health News:HCA Kicks Off 2009 'Caring for the Community' Campaign 2Health News:HIMSS Electronic Health Record Association Applauds Federal Support of EHR Implementation for Hospitals and Physician Practices 2Health News:HIMSS Electronic Health Record Association Applauds Federal Support of EHR Implementation for Hospitals and Physician Practices 3Health News:Morehead Presents Webinar on 'He Said…She Said: How Gender Differences Impact Physician Engagement' 2
(Date:8/1/2014)... -- In the latest call for gender equity in ... 60 doctors and leading medical experts from across the ... and Drug Administration,s (FDA) decision to approve 26 drugs ... dysfunction compared with ZERO for women,s most common complaint, ... by approving the first-ever drug to treat Hypoactive Sexual ...
(Date:8/1/2014)... , August 1, 2014 ... Market by Type (Traditional Wound Closure, Anti infective), Basic ... (Artificial Skin & Skin Substitutes), Pressure Relief Devices, ... MarketsandMarkets, the global Wound Care Market is expected to ... in 2014, growing at a CAGR of 3.2% ...
(Date:8/1/2014)... PLYMOUTH MEETING, Pa. , Aug. 1, 2014 /PRNewswire/ ... that it will host a conference call to report ... 11, 2014 at 9:00 AM ET. CEO Dr. ... will discuss second quarter earnings, provide a corporate ... The update will include clinical development plans for VGX-3100, ...
Breaking Medicine Technology:60+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3
... EAU study conducted with University of Pennsylvania shows ... different approaches,are being used to increase milk production ... at the University of Pennsylvania School of,Veterinary Medicine ... technology created by EAU Technologies, has the potential ...
... study to commence late this year, ... (ASX:,CYT) has selected CYT387, a selective and ... treat myeloproliferative disorders (MPDs). This,follows extensive laboratory ... in an in-vivo model of myeloproliferative,disease., ...
Cached Medicine Technology:Increasing Dairy Milk Production with Electrolyzed Drinking Water 2Increasing Dairy Milk Production with Electrolyzed Drinking Water 3Increasing Dairy Milk Production with Electrolyzed Drinking Water 4Increasing Dairy Milk Production with Electrolyzed Drinking Water 5Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders 2Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: